BMSON Header
보건의료전문가가 아닌 경우, 한국BMS Official Site (https://www.bms.com/kr)을 방문해 주세요.
Log Out My Profile Contact Us

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Oct 26, 2021

Error
Error
Success
Success
foot note heading
BMSON Footer